Zusammenfassung
Neuroradiologisch-interventionelle Eingriff e werden in Kathetertechnik durchgeführt. Der Zugang ist meist perkutan transfemoral. Je nach Art der Erkrankung und den Präferenzen des Interventionalisten wird der Eingriff am wachen Patienten oder in Vollnarkose durchgeführt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Struffert T, Doerfler A. Flachdetektor-CT in der diagnostischen und interventionellen Neuroradiologie. Radiologe 2009; 49: 820–829
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325(7): 445–53.
MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet 1991; 337(8752): 1235–1243
Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361(9352): 107–116
Ringleb PA, Allenberg J, Bruckmann H, et al. for the SPACE Investigators. 30 Day results from the SPACE trial of stentprotected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368: 1239–1247. (Erratum: Lancet 2006; 368: 1238)
Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660–1167
Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010; 375: 985–997
Brott TG, Hobson RW, Howard G, et al. for the CREST Investigators. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis. N Engl J Med 2010; 363: 11–23
Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent- Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol 2008; 7(10): 893–902
Stingele R, Berger J, Alfke K, Eckstein HH, Fraedrich G, Allenberg J, Hartmann M, Ringleb PA, Fiehler J, for the SPACE investigators. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol 2008; 7: 216–222
Jansen O, Fiehler J, Hartmann M, Brückmann H, for the SPACE investigator group. Protection or non-protection in carotid stent angioplasty. The influence of interventional techniques on outcome data from the SPACE trial. Stroke 2009; 40: 841–846
Crawley F, Clifton A, Buckenham T, et al. Comparison of hemodynamic cerebral ischemia and microembolic signals detected during carotid endarterectomy and carotid angioplasty. Stroke 1997; 2: 2460–2464
Whitlow PL, Lylyk P, Londero H, et al. Carotid artery stenting protected with an emboli containment system. Stroke 2002; 33: 1308–1314
Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003; 60(2): 259–266
Koch C, Kucinski T, Eckert B, et al. Endovascular therapy of high-degree stenoses of the neck vessels-stent-supported percutaneous angioplasty of the carotid artery without cerebral protection. Röfo 2002; 174: 1506–1510
Jaeger H, Mathias K, Drescher R, Hauth E, Bockisch G, Demirel E, Gissler HM. Clinical results of cerebral protection with a filter device during stent implantation of the carotid artery. Cardiovasc Intervent Radiol 2001; 24: 249–256
Eckert B, Zeumer H. Editorial comment: Carotid artery stenting with or without protection devices? Strong opinions, poor evidence! Stroke 2003; 34: 1941–1943
Fiehler J, Bakke SJ, Clifton A, Houdart E, Jansen O, Rüfenacht D, Söderman M, Cognard C. Plea of the defence - critical comments on the interpretation of EVA3S, SPACE and ICSS. Neuroradiology 2010; 52: 601–610
Attigah N, Külkens S, Deyle C, Ringleb P, Hartmann M, Geisbüsch P, Bölckler D. Redo Surgery or Carotid Stenting for Restenosis after Carotid Endarterectomy: Results of Two Different Treatment Strategies. Ann Vasc Surg 2010; 24: 190–195
Reiff T, Stingele R, Eckstein HH, Fraedrich G, Jansen O, Mudra H, Mansmann U, Hacke W, Ringleb P; SPACE2-Study Group. Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2 - a three-arm randomisedcontrolled clinical trial. Int J Stroke 2009; 4(4): 294–299
WASID Study Group: Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998; 29: 1389–1392
Chimowitz MI. Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch Neurol 2001; 58(10): 1690–1692
Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305–1316
Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000; 55: 490–497
Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of asymptomatic intracranial arterial stenosis. Circulation 2006; 113: 555–563
Sundt TM Jr, Smith HC, Campbell JK, et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980; 55: 673–680
Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993; 78: 192–198
Marks MP, Wojak JC , Al-Ali F, et al. Angioplasty for Symptomatic Intracranial Stenosis Clinical Outcome. Stroke 2006; 37: 1016–1020
Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998; 19: 1525–1533
Mori T, Kazita K, Chokyu K, et al. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting of carotid and atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000; 21: 249–254
Connors JJ, Wojak JC. Percutneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999; 91: 415–423
Hartmann M, Jansen O. Angioplasty and stenting of intracranial stenosis. Current Opinion in Neurology 2005; 18: 39–45
Gröschel K, Schnaudigel S, Pilgram SM, et al. Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis. Stroke 2009; 40: e340-e347
Lutsep HL, Barnwell SL, Mawad M, et al. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2003; 34: 253
Schillinger M, Exner M, Mlekusch W, et al. Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. Radiology 2003; 227: 516–521
Bose A, Hartmann M, Henkes H, et al. A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses. The Wingspan Study. Stroke 2007; 38: 1531–1537
Fiorella D, Levy EI, Turk AS, et al. US Multicenter Experience With the Wingspan Stent System for the Treatment of ICAD: Periprocedural Results. Stroke 2007; 38: 881–887
Turk AS, Levy EI, Albuquerque FC, et al. Influence of Patient Age and Stenosis Location on Wingspan In-Stent Restenosis. AJNR Am J Neuroradiol 2008; 29: 23–27
Kurre W, Brassel F, Brüning R, et al. Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses - Analysis of the INTRASTENT multicentric registry. Neuroradiology 2011, Jan 11 (Epub ahead of print)
Rohde S, Seckinger J, Hähnel S, Ringleb P, Bendszus M, Hartmann M. Stent design lowers angiographic but not clinical adverse events in stenting ofsymptomatic intracranial stenosis - Results of a single center study with 100 consecutive patients. Int J Stroke 2011 (accepted)
Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009; 72: 2014–2019
Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). ClinicalTrials.gov Identifier: NCT00576693. www.clinicaltrials.gov
National Institute of Neurological Disorders and Stroke (NINDS) Clinical Alert. Angioplasty Combined with Stenting Plus Aggressive Medical Therapy vs. Aggressive Medical Therapy Alone for Intracranial Arterial Stenosis: NINDS Stops Trial Enrollment Due to a Higher Risk of Stroke and Death in the Stented Group. www.ninds.nih.gov. Embargoed for Release April 11, 2011
Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701–705
Virmani R, Farb A, Guagliumi G, Kolodgie FD. Drug-eluting stents: caution and concerns for long-term outcome. Coronary Artery Disease 2004; 15: 313–318
Guagliumi G, Farb A, Musumeci G, Valsecchi O, Tespili M, Motta T, et al. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 2003; 107: 1340–1341
FDA advises physicians of adverse events associated with Cordis Cypher coronary stents. US Food, and Drug Administration Public Health Web Notification 2003; T03–71 October 29
Silber S, Böhm M, Gottwik M, et al. Positionspapier der DGK zur koronaren Stentimplantation. Vermeidung von Tod und lebensbedrohlichen Komplikationen durch zusätzliche Gabe von Clopidogrel. Herz 2006; 31: 83–84
Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. J Am Coll Cardiol 2007; 49: 734–739
Levy EI, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 2004; 100: 688–694
Guglielmi G, Vinuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: Preliminary clinical experience. J Neurosurg 1991; 75: 8–14
Kallmes DF, Ding YH, Dai D, Kadirvel R, Lewis DA, Cloft HJ. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke 2007; 38(8): 2346–2352
Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery 2009; 64: 632–643
Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, orella D. The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011; 32(1): 34–40
Byrne JV, Sohn MJ, Molyneux AJ, Chir B. ve-year experience in using coil emolization for ruptured intracranial aneurysms: outcomes and incidence of late rebleeding. J Neurosurg 1999; 90: 656–663
Vinuela F, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997; 86: 475–482
Cognard C, Weill A, Spelle L, Piotin M, Castaings L, Rey A, Moret J. Long term angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils. Radiology 1999; 212: 348–356
Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267–1274
Molyneux A, Kerr R, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005; 366: 809–817
Forsting M, Wanke I. Endovaskuläre Therapie intrakranieller Aneurysmen: Nervenarzt 2006 77: S31-S38
Jestaedt L, Pham M, Bartrsch A, et al. Efficacy of balloon angioplasty in the treatment of vasospasm after aneurysmal SAH. Clin Neuroradiol 2007; 17: 180–186
Doerfler A, Wanke I, Egelhof T, et al. Aneurysmal rupture during embolization with Guglielmi detachable coils: causes, management, and outcome. AJNR Am J Neuroradiol 2001; 22: 1825–1832
Geyik S, Ertugrul O, Yavuz K, Geyik P, Saatci I, Cekirge HS. Comparison of bioactive coils and bare platinum coils for treatment of intracranial aneurysms: a matched-pair analysis. J Neurosurg 2010; 112(4): 709–713
D'Agostino SJ, Harrigan MR, Chalela JA, Nicholas JS, Deveikis SI, Jones TM, Deveikis JP. Clinical experience with Matrix2 360 degrees coils in the treatment of 100 intracranial aneurysms. Surg Neurol 2009; 72(1): 41–47
White PM, Raymond J. Endovascular coiling of cerebral aneurysms using "bioactive" or coated-coil technologies: a systematic review of the literature. AJNR Am J Neuroradiol 2009; 30(2): 219–226
Moret J, Cognard C, Weill A, Castaings L, Rey A. Reconstruction technic in the treatment of wide-neck intracranial aneurysms. Long term angiographic and clinical results. Apropos 56 cases. J Neuroradiol 1997; 24: 30–44
Wanke I, Doerfler A, Schoch B, et al. Treatment of Wide-Necked Intracranial Aneurysms with a Self-Expanding Stent System: Initial Clinical Experience. AJNR Am J Neuroradiol 2003; 24: 1192–1199
Piotin M, Blanc R, Spelle L, Mounayer C, Piantino R, Schmidt PJ, Moret J. Stent-Assisted Coiling of Intracranial Aneurysms. Clinical and Angiographic Results in 216 Consecutive Aneurysms. Stroke 2010; 41(1): 110–115
Cebral JR, Mut F, Raschi M, Scrivano E, Ceratto R, Lylyk P, Putman CM. Aneurysm rupture following treatment with flow-diverting stents: computational hemodynamics analysis of treatment. AJNR Am J Neuroradiol 2011; 32(1): 27–33
Kulcsár Z, Houdart E, Bonafé A, et al. Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol 2011; 32: 20–25
Kulcsár Z, Wetzel SG, Augsburger L, Gruber A, Wanke I, Rüfenacht DA. Eect of flow diversion treatment on very small ruptured aneurysms. Neurosurgery. 2010; 67(3): 789–793
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986; 65: 476–483
Cognard C, Gobin YP, Pierot L, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 1995; 194: 671–680
Wanke I, Panagiotopoulos V, Forsting M. Das Risiko intrazerebraler Gefäßmissbildungen. Fortschr Röntgenstr 2007; 179: 365–372
Nataf F, Meder JF, Roux FX, et al. Angioarchitecture associated with haemorrhage in cerebral arteriovenous malformations: a prognostic statistical model. Neuroradiology 1997; 39: 52–58
Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001; 48: 984–995
Forsting M (ed). Intracranial vascular malformations and aneurysms. Springer, Berlin Heidelberg 2004
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hartmann, M. (2012). Interventionelle neuroradiologische Techniken. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16911-3_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-16911-3_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16910-6
Online ISBN: 978-3-642-16911-3
eBook Packages: Medicine (German Language)